Skip to content
    ALLO stock page

    Allogene Therapeutics, Inc.

    ALLO · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 12, 2026

      Allogene Therapeutics Q2 FY26 — Strategic Progress in Allogeneic CAR-T and Pipeline Advancement

      Read the brief

    Browse all US companies on the earnings-call register.